한국어
Quantus

Sukgyung AT

357550 · KOSDAQ
₩32,900+0.00%
2026-09-04 close

Sukgyung AT last closed at ₩32,900 (+0.00%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

C
Overall: 화학 77/109 · top 70%
Factor composite · relative position in sector

PER 41.39 · PBR 4.5 — own-history percentile 86/100 · 86/100

Open self-history band
PER86/100
PBR86/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 8.56
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
8.56
Beneish M-Score
-2.31

No statistical flag

Sloan accrual
-0.12%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Why has this company moved this way?

Auditable observations with the original numeric evidence.

차입 증가 → 이자부담 → 수익성 악화

Critical

부채가 +124.7% 늘며 이자보상배율이 287.7x에서 124.1x로 하락했다. ROE도 9.7%에서 5.1%로 낮아져 차입 부담이 수익성을 누르고 있다.

Evidence

부채 YoY +124.7%이자보상배율 287.7x→124.1xROE 9.7%→5.1%

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

4/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score4/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Balance sheetWarning

부채총계 급증 (+125%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업이익률 악화 (28.7% → 14.6%, -14.1%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Margin trendWarning

영업외손익 급변 (영업이익 대비 117% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

화학

This stock is in 화학: revenue rank 105 of 108, share 0%.

105 / 1080%revenue share

Who dominates this industry?

  1. 1LG화학31.9%
  2. 2롯데케미칼13.3%
  3. 3금호석유화학4.7%
  4. 4DL3.7%
  5. 5코오롱인더3.2%
  6. 6석경에이티0%

Concentration

DistributedCR3 49.9%
HHI 1,299108 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
8.84
Direction
확대
Level
보통
Years
6

Value lens

P90/P10
9.5
Median P/B
0.68
Level
넓음
n
96

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
14.6%
Interest coverage
124.1x
Return on equity (ROE)
10.9%

Operating margin −5pp

Tolerable
Interest coverageBase 124.1x adverse case 81.7x
Return on equity (ROE)Base 10.9% adverse case 3.3%

Revenue −15%

Tolerable
Interest coverageBase 124.1x adverse case 105.5x
Return on equity (ROE)Base 10.9% adverse case 4.3%

Interest rate +2pp

Tolerable
Interest coverageBase 124.1x adverse case 9.9x
Return on equity (ROE)Base 10.9% adverse case 4.6%

Interest coverage limit

Current margin 14.5pp

Interest coverage limit at an operating margin of 0.1%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-18

Suppliers disclosed by the company in its 2026-03-18 annual report.

Suppliers without disclosed amount

YtterbiumEthanolYtterbiumtrioxideIMCTTOYOTATSUSHOMATERIALYtterbiumFluorideYbFSiOSeriesSilicaBarium+6 more

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 임형섭39.74%2026-06-22 · 증감 -1.09%p

Connections

AI-extracted related companies · for reference

Suppliers
BASFDuPont
🔗 See in the full market map →

Recent filings

Sukgyung AT's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Sukgyung AT
What technical signals does Sukgyung AT (357550) have?
Sukgyung AT current technical signals: no active technical signal.
Is Sukgyung AT a cup-and-handle pattern?
No. Sukgyung AT has no valid cup-and-handle signal right now.
What are Sukgyung AT's financials and valuation?
Sukgyung AT's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy